tiprankstipranks
Icosavax (ICVX)
NASDAQ:ICVX
US Market
Holding ICVX?
Track your performance easily

Icosavax (ICVX) Income Statement

73 Followers

Icosavax Income Statement

Last quarter (Q3 2023), Icosavax's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Icosavax's net income was $-22.02M. See Icosavax’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19
Total Revenue
-$ 582.00K$ 7.80M$ 0.00$ 0.00
Cost of Revenue
-----
Gross Profit
$ 582.00K$ 582.00K$ 7.80M--
Operating Expense
$ 55.62M$ 95.64M$ -73.66M$ 18.71M$ 5.40M
Operating Income
$ -105.30M$ -95.06M$ -65.86M$ -18.71M$ -5.40M
Net Non Operating Interest Income Expense
$ -263.00K$ 3.30M$ -205.00K$ -331.00K$ 101.00K
Other Income Expense
$ -3.89M$ 403.00K$ -754.00K$ 187.00K-
Pretax Income
$ -96.15M$ -92.16M$ -65.46M$ -18.85M$ -5.30M
Tax Provision
-----
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -96.15M$ -92.16M$ -65.46M$ -18.85M$ -5.97M
Basic EPS
$ -2.82$ -2.31$ -3.73$ -1.82$ -0.58
Diluted EPS
$ -2.22$ -2.31$ -3.73$ -1.82$ -0.58
Basic Average Shares
$ 175.79M$ 39.73M$ 17.97M$ 10.24M$ 10.24M
Diluted Average Shares
$ 175.79M$ 39.73M$ 17.97M$ 10.24M$ 10.24M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 55.62M$ 95.64M$ -73.66M$ 18.71M$ 5.40M
Net Income From Continuing And Discontinued Operation
$ -96.51M$ -91.76M$ -65.46M$ -18.85M$ -5.30M
Normalized Income
$ -38.33M$ -72.81M-$ -19.04M$ -5.30M
Interest Expense
---$ 331.00K-
EBIT
$ -101.15M$ -95.46M$ -65.11M$ -18.52M$ -5.40M
EBITDA
$ -102.85M$ -96.09M$ -65.01M$ -18.52M$ -5.40M
Currency in USD

Icosavax Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis